NUAI vs NVDA

The company exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9 and the absence of a calculable Altman Z-Score due to negative equity. With a Price/Book ratio of -104.29 and an astronomical Price/Sales ratio of 539.76, the stock is fundamentally decoupled from its financial reality. Despite a speculative 1-year price surge of 474.2%, the operating margin is catastrophic at -2260.18%, indicating an unsustainable business model. The lack of intrinsic value or a Graham Number confirms that the current market price is driven by momentum rather than fundamental value.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.